Skip to main content
Clinical Trials/NCT00924755
NCT00924755UnknownPhase 4

Early Outcome of Inguinal Hernia Repair With Biomerix Surgical Mesh Using the Lichtenstein Technique

Biomerix4 sites in 1 country25 target enrollmentStarted: June 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Sponsor
Biomerix
Enrollment
25
Locations
4
Primary Endpoint
Technical success with no complications through 6 weeks.

Study Overview

Brief Summary

The purpose of this study is to assess the early outcomes when using the Biomerix Revive™ as a tension-free onlay patch, Lichtenstein-style, in patients who are candidates for primary, unilateral, open inguinal hernia repair.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • male ≥19 years old
  • symptomatic and palpable inguinal hernia
  • candidate for unilateral, primary, open inguinal hernia repair using the Lichtenstein technique
  • will comply with required follow-up study visits
  • willing and able to provide written informed consent

Exclusion Criteria

  • life expectancy of <3 years
  • strangulated hernia
  • urologic disorder and/or previous urologic surgery in the testicular area (with the exception of prostate surgery)
  • active abdominal surgical condition such as bowel obstruction or perforation
  • local or systemic infection or peritonitis
  • known disease that impairs wound healing
  • anti-platelet therapy (other than aspirin) for >7 days preceding the surgical procedure
  • previous ipsilateral groin incision
  • receiving immunosuppressive therapy and/or has undergone radiation therapy to the affected groin area
  • uncontrolled insulin-dependent diabetic with Hgb1Ac greater than 8
  • advanced cirrhosis with Child-Turcott Class of C or higher
  • severe COPD requiring home oxygen
  • diagnosed with chronic pain syndrome or is undergoing treatment for pain management
  • candidate for another major surgical procedure with the inguinal hernia repair
  • enrolled in another investigational study that may confound the results of this study
  • known drug abuser
  • on anti-psychotic medications
  • Worker's Compensation case

Outcomes

Primary Outcomes

Technical success with no complications through 6 weeks.

Time Frame: 6 weeks

Secondary Outcomes

  • Hernia recurrence(1 year)
  • Pain and functional status(10 day, 6 weeks, 6 months 1 year)
  • Incidence of complications(10 days, 6 weeks, 6 months, 1 year)

Investigators

Sponsor
Biomerix
Sponsor Class
Industry

Study Sites (4)

Loading locations...

Similar Trials